Losartan Co 50/12.5 ,100/12.5, 100/25 Austell 50 mg, 100 mg, 12.5 mg, 25 mg Tablet
PDF Leaflet Revision Date: 25 April 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension.
Dosage (summary)
Starting dose: 50/12.5 mg once daily; max: 100/25 mg once daily.
Onset of Action / Duration
Onset: 3 weeks, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Paediatric population
Pregnancy & Breastfeeding
Contraindicated in pregnancy; avoid breastfeeding.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
- Antidiabetic drugs
Contraindications
- Hypersensitivity
- Severe renal impairment
- Severe hepatic impairment
- Pregnancy
- Angioedema history
Common side effects
- Dizziness
- Hyperkalaemia
- Fatigue
- Hypotension
Counselling Points
- Monitor blood pressure regularly.
- Report signs of angioedema.
- Avoid potassium supplements.
- Stay hydrated.
Serious warnings
- Angioedema risk
- Hypotension in volume-depleted patients
- Electrolyte imbalances
Important Disclaimer
The Losartan Co 50/12.5 ,100/12.5, 100/25 Austell 50 mg, 100 mg, 12.5 mg, 25 mg Tablet professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
